|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/12 | (2006.01) |
| A61K 39/40 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 2305295 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10010739.0 |
| Date of filing the European patent application | 2005-09-20 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0421082 | 2004-09-22 | GB | |
| 0421078 | 2004-09-22 | GB | |
| 0421081 | 2004-09-22 | GB | |
| 0421079 | 2004-09-22 | GB | |
| 0503143 | 2005-02-15 | GB |
| (72) |
Castado, Cindy, BE
Lecrenier, Nicolas Pierre Fernand, BE
Neyt, Ceclie Anne, BE
Poolman, Jan, BE
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | Antibody composition for use in vaccination against staphylococcei |
| Antibody composition for use in vaccination against staphylococcei |